Gonadotropin-Releasing Hormone Antagonist Protects Against Ɣ-Radiation-Induced Female Infertility in Rats
DOI:
https://doi.org/10.48165/Keywords:
Radiation, Oxidative Stress, Apoptosis, Low CaloricAbstract
Radiotherapy is one of the most common and effective cancer treatments. However, it has a profound impact on ovarian function, leading to premature ovarian failure. With the hope of preserving fertility in cancer survivors, the need for an effective radioprotective therapy is evident. The present study investigated the mechanism of potential radioprotective effect of cetrorelix on radiation-induced ovarian failure and whether cetrorelix can stimulate in vivo follicular development in experimental rats. Immature female rats were either exposed to gamma radiation (3.2 Gy, LD20), once and/or treated with cetrorelix (0.5 mg/kg), once daily for 10 days before irradiation. Histopathological examination further confirmed the radioprotective efficacy of cetrorelix and its in-vivo effect on ovarian follicles’ maturation .Cetrorelix significantly reversed the oxidative stress effects of radiation that was evidenced by increasing in lipid peroxide level and decreasing in glutathione level. In conclusion, cetrorelix showed a radioprotective effect.
References
Drians, I., Smitz, J., & Jacquet, P. (2009). The current knowledge on radiosensitivity of ovarian follicle development stages. Human Reproduction Update, 15, 359.
Celik, E., Celik, O., Kumbak, B., Yilmaz, E., Turkcuoglu, I., Simsek, Y., Karaer, A., Minareci, Y., Ozerol, E., & Tanbek, K. (2012). A comparative study on oxidative and antioxidative markers of serum and follicular fluid in GnRH agonist and antagonist cycles. Journal of Assisted Reproduction and Genetics, 29, 1175.
Check, J. H., & Katsoff, B. (2008). Ovulation induction and pregnancy in a woman with premature menopause following gonadotropin suppression with the gonadotropin releasing hormone antagonist, cetrorelix—a case report. Clinical and Experimental Obstetrics & Gynecology, 35, 10.
Gosden, R. G., Wade, J. C., Fraser, H. M., Sandow, J., & Faddy, M. J. (1997). Impact of congenital or experimental hypogonadotrophism on the radiation sensitivity of the mouse ovary. Human Reproduction, 12, 2483.
Gurgan, T., Salman, C., & Demirol, A. (2008). Pregnancy and assisted reproduction techniques in men and women after cancer treatment. Placenta, 29(Suppl. B), 152.
Huirne, J. A., Homburg, R., & Lambalk, C. B. (2007). Are GnRH antagonists comparable to agonists for use in IVF? Human Reproduction, 22, 2805.
Li, X., Kang, X., Deng, Q., Cai, J., & Wang, Z. (2013). Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: A controlled experimental animal study. Reproductive Biology and Endocrinology, 11, 16.
Lutchman Singh, K., Davies, M., & Chatterjee, R. (2005). Fertility in female cancer survivors: Pathophysiology, preservation and the role of ovarian reserve testing. Human Reproduction Update, 11, 69.
Meirow, D., Assad, G., Dor, J., & Rabinovici, J. (2004). The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Human Reproduction, 19, 1294.
Murase, M., Uemura, T., Gao, M., Inada, M., Funabashi, T., & Hirahara, F. (2005). GnRH antagonist-induced down-regulation of the mRNA expression of pituitary receptors: Comparisons with GnRH agonist effects. Endocrine Journal, 52, 131.
Parborell, F., Irusta, G., Vitale, A., Gonzalez, O., Pecci, A., & Tesone, M. (2005). Gonadotropin-releasing hormone antagonist antide inhibits apoptosis of preovulatory follicle cells in rat ovary. Biology of Reproduction, 72, 659.
Said, R. S., El-Demerdash, E., Nada, A. S., & Kamal, M. M. (2016). Resveratrol inhibits inflammatory signaling implicated in ionizing radiation-induced premature ovarian failure through antagonistic crosstalk between silencing information regulator 1 (SIRT1) and poly(ADP-ribose) polymerase 1 (PARP-1). Biochemical Pharmacology, 103, 140.
Said, R. S., Nada, A. S., & El-Demerdash, E. (2012). Sodium selenite improves folliculogenesis in radiation-induced ovarian failure: A mechanistic approach. PLOS ONE, 7, 50928.
Skinner, M. K. (2005). Regulation of primordial follicle assembly and development. Human Reproduction Update, 11, 461.
Stroud, J. S., Mutch, D., Rader, J., Powell, M., Thaker, P. H., & Grigsby, P. W. (2009). Effects of cancer treatment on ovarian function. Fertility and Sterility, 92, 417.
Thomakos, N., Trachana, S. P., Koutroumpa, I., Rodolakis, A., & Gavalas, N. G. (2015). Molecular aspects and clinical methods for preserving ovarian reserves in women receiving cancer treatment. Clinical and Experimental Obstetrics & Gynecology, 42, 416.
Trombly, D. J., Woodruff, T. K., & Mayo, K. E. (2009). Suppression of Notch signaling in the neonatal mouse ovary decreases primordial follicle formation. Endocrinology, 150, 1014.
Vassilakopoulou, M., Boostandoost, E., Papaxoinis, G., de La Motte Rouge, T., Khayat, D., & Psyrri, A. (2016). Anticancer treatment and fertility: Effect of therapeutic modalities on reproductive system and functions. Critical Reviews in Oncology/Hematology, 97, 328.
Whitehead, J., Toledo, M. G., & Stern, C. J. (2011). A pilot study to assess the use of the gonadotrophin antagonist cetrorelix in preserving ovarian function during chemotherapy. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 51, 452.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
